Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients With Posttransplant Lymphoproliferative Disorder: A Single-Center Retrospective Study

18 August 2026 : Original article

Ying Liu^{ABCDEFG 1,2,3,4,5}, Ru-Zhou Cai

^{ABCDEF 2,3,4,5,6}, Wei Qu^{ACDE 2,3,4,5,6}, Lin Wei

^{ADE 2,3,4,5,6}, Zhi-Gui Zeng^{ADE 2,3,4,5,6}, Zhi-Jun Zhu^{ACDE 2,3,4,5,6}, Li-Ying Sun^{ABCDEFG 2,3,4,5,7*}

DOI: 10.12659/AOT.952021

Ann Transplant 2026; 31:e952021

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Liver biopsy in case 3 shows no evidence of rejection or graft fibrosis at 1 and 2 years after immunosuppression withdrawal.

Back to the Article